Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | PAM | P19021 | 2/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL643820 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL7954252 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL18996 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL67579 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL7034679 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL10868296 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL7170043 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL9257236 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL3031778 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 | |
| SCHEMBL339257 | 1.00 | HTR2C (0.66) | HTR2CNAAADGKAPAMGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118530412-A | Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery | 深圳好电科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-111990477-B | Starch-based steady-state vegetable oil compound and preparation method thereof | 华南理工大学 | 2022-05-03 | — | — | CN | claimed |
| CN-111990477-A | Starch-based steady-state vegetable oil compound and preparation method thereof | 华南理工大学 | 2020-11-27 | — | — | CN | claimed |
| CN-1169514-C | Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism | ���ŷ� | 2004-10-06 | — | — | CN | claimed |
| CN-1312065-A | Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism | OREAL INC L (FR) | 2001-09-12 | — | — | CN | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250152518-A1 | PEG LIPIDS AND USES THEREOF | MODERNATX, INC. (US) | 2025-05-15 | — | — | US | disclosed |
| EP-4511439-A1 | ORGANIC HEAT TRANSFER SYSTEM, METHOD, AND FLUID | The Lubrizol Corporation (US) | 2025-02-26 | — | — | EP | disclosed |
| EP-4511438-A1 | ORGANIC HEAT TRANSFER SYSTEM, METHOD, AND FLUID | The Lubrizol Corporation (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119053674-A | Organic heat transfer systems, methods, and fluids | 路博润公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119053675-A | Organic heat transfer systems, methods, and fluids | 路博润公司 | 2024-11-29 | — | — | CN | disclosed |
| US-12151029-B2 | PEG lipids and uses thereof | MODERNATX, INC. (US) | 2024-11-26 | — | — | US | disclosed |
| EP-0268324-A2 | Ion-pair complex conditioning agent and compositions containing same | THE PROCTER & GAMBLE COMPANY (US) | 1988-05-25 | — | — | EP | disclosed |
| EP-0264977-A1 | Detergency builders and built detergents | THE PROCTER & GAMBLE COMPANY (US) | 1988-04-27 | — | — | EP | disclosed |
| CN-87106833-A | Heterogeneous ring compound | — | 1988-04-27 | — | — | CN | disclosed |
| EP-0212723-A2 | Built liquid detergents | THE PROCTER & GAMBLE COMPANY (US) | 1987-03-04 | — | — | EP | disclosed |
| EP-0206513-A1 | Laundry detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0201124-A2 | Cleaning compositions | Procter & Gamble European Technical Center (BE) | 1986-11-12 | — | — | EP | disclosed |
| US-4096077-A | LUBRICATING OILS, BENZOTRIAZOLES, HALF-ACIDS, HALF-ESTERS, HALF-AMIDES, HALF-THIOESTERS | STANDARD OIL COMPANY (INDIANA) (US) | 1978-06-20 | — | — | US | disclosed |
| US-3953616-A | POTATOES, 1A-2A SALTS OF MONOALKYL FUMARATES AND MALEATES | PFIZER INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250152518-A1 | PEG LIPIDS AND USES THEREOF | LIPA, LIPG, LIPC | HTR2C 4448/4885NAAA 630/4885DGKA 383/4885 |
| US-12151029-B2 | PEG lipids and uses thereof | LIPA, LIPG, LNPEP | HTR2C 4379/4885NAAA 691/4885DGKA 433/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | HTR2C 129/4885NAAA 1321/4885DGKA 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.